Top Markets
Coin of the day
Welgene Biotech Co.,Ltd. Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661
Classement en actions #31669
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Prix de l'action
$0.53422367
Capitalisation boursière
$12.45M
Changement (1 jour)
0.30%
Changement (1 an)
-19.98%
Pays
TW
Échange Welgene Biotech Co.,Ltd. (6661)

Catégorie

Ratio P/B pour Welgene Biotech Co.,Ltd. (6661)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Welgene Biotech Co.,Ltd., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Welgene Biotech Co.,Ltd. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US